Lotz, J P <br/><br/>
Tandem high-dose chemotherapy with ifosfamide, carboplatin, and teniposide with autologous bone marrow transplantation for the treatment of poor prognosis common epithelial ovarian carcinoma.  [electronic resource] 

 -  Cancer  Jun 1996 
 - 2550-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/(SICI)1097-0142(19960615)77:12<2550::AID-CNCR19>3.0.CO;2-R  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Bone Marrow Transplantation<br/>Carboplatin--administration & dosage<br/>Carcinoma--therapy<br/>Combined Modality Therapy<br/>Female<br/>Humans<br/>Ifosfamide--administration & dosage<br/>Middle Aged<br/>Ovarian Neoplasms--therapy<br/>Survival Analysis<br/>Teniposide--administration & dosage<br/>Transplantation, Autologous